Bayer Aktiengesellschaft (ETR:BAYN) Trading Down 3%

Bayer Aktiengesellschaft (ETR:BAYNGet Rating)’s stock price dropped 3% during mid-day trading on Wednesday . The stock traded as low as €55.23 ($57.53) and last traded at €55.52 ($57.83). Approximately 3,472,768 shares were traded during mid-day trading, The stock had previously closed at €57.24 ($59.63).

The firm has a fifty day simple moving average of €62.25 and a 200-day simple moving average of €57.69. The firm has a market cap of $54.54 billion and a P/E ratio of 24.79. The company has a debt-to-equity ratio of 113.14, a current ratio of 1.23 and a quick ratio of 0.84.

Bayer Aktiengesellschaft Company Profile (ETR:BAYN)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.

Featured Articles

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.